Figure 5.
Figure 5. HUVECs and HMVECs express the CD160 receptor. (A) HUVECs, HMVECs, HAOSMCs, and fibroblasts in primary culture were analyzed by flow cytometry after incubation with anti-CD8-, anti-CD85d-, anti-CD85j-, or CL1-R2 (anti-CD160)-specific mAbs (open profiles) or IgG isotype controls (filled profiles), followed by PE-labeled conjugates. Results are representative of 6 independent experiments. (B) CD160 mRNA was expressed by HUVECs and NK92 cells (positive control) but notbyCD4+ T cells (negative control). RT-PCR analysis, using CD160-specific primers, compared with β-actin control primers. (C) Predicted amino acid sequence alignment of CD160 expressed in HUVECs and NK92. Dotted lines indicate identity.

HUVECs and HMVECs express the CD160 receptor. (A) HUVECs, HMVECs, HAOSMCs, and fibroblasts in primary culture were analyzed by flow cytometry after incubation with anti-CD8-, anti-CD85d-, anti-CD85j-, or CL1-R2 (anti-CD160)-specific mAbs (open profiles) or IgG isotype controls (filled profiles), followed by PE-labeled conjugates. Results are representative of 6 independent experiments. (B) CD160 mRNA was expressed by HUVECs and NK92 cells (positive control) but notbyCD4+ T cells (negative control). RT-PCR analysis, using CD160-specific primers, compared with β-actin control primers. (C) Predicted amino acid sequence alignment of CD160 expressed in HUVECs and NK92. Dotted lines indicate identity.

Close Modal

or Create an Account

Close Modal
Close Modal